Stifel Financial’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Stifel Financial's VCYT Position: Q2 2026 in Review
Stifel Financial reduced its Veracyte (VCYT) stake by 16% in Q2 2026, selling an estimated $200K and leaving 25,274 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2305.
Stifel Financial first reported a position in VCYT in Q2 2019 and has held it in 29 quarters since. The position peaked at $2.03M in Q4 2025. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Stifel Financial held 25,274 shares of Veracyte worth $1.48M as of Q2 2026.
- Stifel Financial sold 4,763 Veracyte shares in Q2 2026, an estimated $200K.
- Veracyte made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #2305 holding.
- Stifel Financial first reported a position in Veracyte in Q2 2019 and has held it in 29 quarters since.
- Stifel Financial's Veracyte position peaked at $2.03M in Q4 2025.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.